IGF-1R peptide vaccine (Ohio State University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIGF-1R peptide vaccine (Ohio State University)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionInsulin-like growth factor I receptor modulators

TargetsInsulin-like growth factor I receptor

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesThe Ohio State University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe Ohio State University

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A